Literature DB >> 10147025

Should indirect costs and benefits be included?

D A Henry.   

Abstract

Mesh：

Year:  1992        PMID： 10147025     DOI： 10.2165/00019053-199201060-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  2 in total

Review 1.  Sumatriptan. A pharmacoeconomic review of its use in migraine.

Authors:  A J Coukell; H M Lamb
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

2.  Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy.

Authors:  Thomas Faunce; Evan Doran; David Henry; Peter Drahos; Andrew Searles; Brita Pekarsky; Warwick Neville
Journal:  Global Health       Date:  2005-10-06       Impact factor: 4.185
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.